Biomarker of Lung Injury in ARDS Patients Receiving ECMO Support

NCT01967602 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2013-10-23

No results posted yet for this study

Summary

The goal of this project is to find a marker expression that the investigators can use to trace symptom progression and develop a more efficient therapy to enhance ARDS patient survival rate and better post-ICU life quality.

Conditions

  • ARDS
  • Multi-organ Failure

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shuenn-Wen Kuo, MD · National Taiwan University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01967602 on ClinicalTrials.gov